Galera Therapeutics, Inc. (GRTX)
OTCMKTS · Delayed Price · Currency is USD
0.0239
+0.0019 (8.64%)
Feb 12, 2026, 1:56 PM EST
Galera Therapeutics Market Cap
Galera Therapeutics has a market cap or net worth of $1.8 million as of February 12, 2026. Its market cap has decreased by -45.83% in one year.
Market Cap
1.80M
Enterprise Value
150.96M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since November 7, 2019, Galera Therapeutics's market cap has decreased from 292.35M to 1.80M, a decrease of -99.38%. That is a compound annual growth rate of -55.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 1.80M | 8.64% |
| Dec 31, 2025 | 1.66M | -51.98% |
| Dec 31, 2024 | 3.46M | -56.28% |
| Dec 29, 2023 | 7.91M | -81.38% |
| Dec 30, 2022 | 42.47M | -65.01% |
| Dec 31, 2021 | 121.35M | -52.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VitaSpring Biomedical | 2.30M |
| ZyVersa Therapeutics | 2.02M |
| Exousia Pro | 1.96M |
| Neon Bloom | 1.85M |
| Agentix | 1.68M |
| Carisma Therapeutics | 1.63M |
| inTerra Resources | 1.49M |
| International Stem Cell | 1.32M |